Bone Biologics (BBLG) Assets Average (2016 - 2025)
Bone Biologics has reported Assets Average over the past 2 years, most recently at $1.2 million for Q4 2017.
- Quarterly Assets Average rose 67.35% to $1.2 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2017, up 67.35% year-over-year, with the annual reading at $748399.5 for FY2017, 33.42% down from the prior year.
- Assets Average was $1.2 million for Q4 2017 at Bone Biologics, down from $1.3 million in the prior quarter.
- Over five years, Assets Average peaked at $3.3 million in Q2 2016 and troughed at $736267.0 in Q4 2016.